Sandu Pharma. Nine Monthly Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Dec-2022	Dec-2021	--	--	--
Gross Sales	50.08	54.08	--	--	--
Excise Duty	--	--	--	--	--
Net Sales	50.08	54.08	--	--	--
Other Operating Income	--	--	--	--	--
Other Income	0.28	0.05	--	--	--
Total Income	50.37	54.13	--	--	--
Total Expenditure	48.08	51.78	--	--	--
PBIDT	2.29	2.36	--	--	--
Interest	0.06	0.09	--	--	--
PBDT	2.22	2.27	--	--	--
Depreciation	0.38	0.40	--	--	--
Minority Interest Before NP	--	--	--	--	--
Tax	0.56	0.55	--	--	--
Deferred Tax	0.03	--	--	--	--
Reported Profit After Tax	1.25	1.32	--	--	--
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	1.25	1.32	--	--	--
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	1.25	1.32	--	--	--
EPS (Unit Curr.)	1.35	1.67	--	--	--
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	9.66	7.92	--	--	--
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	4.57	4.36	--	--	--
PBDTM(%)	4.43	4.20	--	--	--
PATM(%)	2.50	2.44	--	--	--

QuickLinks for Sandu Pharmaceuticals Ltd.